The mechanism and pharmacodynamics of 2-((1H-indol-3-yl)thio/sulfinyl)-N-pheny acetamide derivative as a novel inhibitor against human respiratory syncytial virus

• Main Authors: Ningning Cheng (Author), Nan Jiang (Author), Yuanhui Fu (Author), Zhuxin Xu (Author), Xianglei Peng (Author), Jiemei Yu (Author), Shan Cen (Author), Yucheng Wang (Author), Guoning Zhang (Author), Yanpeng Zheng (Author), Jinsheng He (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Human respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection worldwide. Until now, there are no licenced vaccines or effective antiviral drugs against RSV infections. In our previous work, we found 2-((1H-indol-3-yl)thio/sulfinyl)-N-pheny acetamide derivatives (4-4...